Compare XPRO & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XPRO | OMCL |
|---|---|---|
| Founded | 1938 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Computer Manufacturing |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2026 | 2000 |
| Metric | XPRO | OMCL |
|---|---|---|
| Price | $16.95 | $37.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $17.50 | ★ $57.86 |
| AVG Volume (30 Days) | ★ 747.1K | 412.3K |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $2.50 | $4.40 |
| Revenue Next Year | $6.38 | $4.12 |
| P/E Ratio | ★ N/A | $48.19 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $12.44 | $29.09 |
| 52 Week High | $19.23 | $51.84 |
| Indicator | XPRO | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 64.53 |
| Support Level | $15.13 | $35.25 |
| Resistance Level | $17.12 | $37.64 |
| Average True Range (ATR) | 0.84 | 1.17 |
| MACD | 0.09 | 0.24 |
| Stochastic Oscillator | 96.84 | 98.68 |
Expro Ltd is an energy services company that provides energy services and well solutions for the oil and gas industry. Its service portfolio includes well construction, well flow management, subsea well access, well intervention, and well integrity solutions. The company serves exploration and production companies in onshore and offshore environments across multiple countries.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.